The Future of Systemic Lupus Erythematosus Diagnosis and Treatment: A Discussion with the Experts (Internet Activity) (EM2211B)

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease that is difficult to diagnose and challenging to treat. It can involve multiple organ systems, leading to significant reduction in both the quality of life and overall lifespan of affected individuals. Despite published criteria designed for research studies, it remains difficult to recognize patients in practice, especially early in the course of disease. The management of patients is hampered by the lack of modern treatment guidelines and only a few therapies specifically developed for lupus. This internet activity, designed for physicians and researchers, consists of 8 sessions that bring SLE experts together to explain, via didactic lecture and case studies, current information on the cause of this mystifying illness, identify the best way to identify patients in practice, and describe the current and future therapies for lupus patients.

Method of Participation

This continuing medical education enduring material is in a video format. 

To receive a maximum of 9.0 AMA PRA Category 1 Credit(s)™ and ABIM MOC points, you should:

  1. View the videos in this enduring material.
  2. Complete the posttests (A passing score of 75% is required).
  3. Complete and submit the CME evaluation form.

The estimated time to complete this activity, including review of the materials, is 9.0 hours. Eligible credit amounts are listed with each video. 

Hardware/software requirements: Activities should be run with recent versions of common browsers, including Internet Explorer, Mozilla Firefox, and Google Chrome.

If you have questions about the participation process, please e-mail the UT Southwestern Medical Center, cmeregistrations@utsouthwestern.edu.

Target Audience

THIS ACTIVITY IS INTENDED FOR PROVIDERS IN THE SPECIALTIES OF: 

  • Rheumatology
  • Nephrology

Learning Objectives

  • Describe the current knowledge of the pathophysiology of lupus. 
  • Identify appropriate criteria and studies to accurately diagnose lupus. 
  • Select the most appropriate therapy options for lupus patients, taking into consideration differing organ-specific manifestations of the condition, such as lupus nephritis. 
  • Identify opportunities to advance research in lupus. 
  • Describe optimal treatment protocols for lupus nephritis.
Course summary
Available credit: 
  • 9.00 AMA
  • 9.00 Attendance
Course opens: 
06/23/2022
Course expires: 
07/07/2023
Cost:
$0.00
Video contentEligible AMA PRA Category 1 Credit(s)™ Eligible points in the ABIM MOC program
Socioeconomic Determinants in Lupus1.251.25
Steroids and Lupus1.01.0
Reproductive Issues in Lupus1.251.25
Patient Reported Outcomes/Patient Outcomes1.01.0
Pathogenesis of Lupus1.251.25
Epidemiological Factors and Pre-clinical Lupus1.251.25
Trials and Outcome Measures1.01.0
Novel Targets and Interventions (Bench to Bedside)1.01.0

 

Online Activity
United States

Course Directors

David Karp, M.D., Ph.D.
Chief, Division of Rheumatic Diseases
UT Southwestern Medical Center

Kathryn Dao, M.D.
Associate Professor - Department of Internal Medicine, Division of Rheumatology
UT Southwestern Medical Center
 

Disclosure of Financial Relationships 

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), The University of Texas Southwestern Medical Center, Office of Continuing Medical Education (UTSW CME) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of any ineligible company, and promote improvements or quality in healthcare.  In accordance with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all persons in the position to control the content of an education activity are required to disclose all financial relationships in any amount occurring within the past 24 months with any ineligible company producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients.  UT Southwestern also considers ineligible those companies producing, marketing, selling, re-selling, or distributing healthcare products in development for future use on patients, such as healthcare product research companies.  All reported financial relationships with ineligible companies are reviewed for relevancy and then mitigated through a content review process prior to the activity (where applicable).  

The following is a listing of all individuals that contributed to the educational content of this activity and any reported financial relationships within the last 24 months: 

NAME

ROLE

RELATIONSHIP

COMPANY

Puneet Bajaj, M.D.

Moderator

None

N/A

Bonnie Bermas, M.D.

Moderator, Peer Reviewer

None

N/A

Ashira D. Blazer, M.D., MSCI

Speaker

Independent Contractor
Independent Contractor

GSK
Novartis

Eliza Chakravarty, M.D.

Speaker

None

N/A

Megan E. B. Clowse, M.D., MPH

Speaker

Grant or Contract
Grant or Contract
Independent Contractor

Exagen
Pfizer
UCB

Karen H. Costenbader, M.D., MPH

Speaker

Professional Services
Professional Services
Professional Services
Professional Services
Professional Services
Professional Services
Grant or Contract
Grant or Contract
Grant or Contract

Neutrolis
Astra Zeneca
Merck
Lilly
Janssen
Glaxo Smith Kline
Merck
Gilead
Exagen

Kathryn Dao, M.D.

Course Director, Moderator

Independent Contractor
Independent Contractor

Bristol Myers Squibb
Novartis

Lesley Davila, M.D.

Moderator

None

N/A

Candace Feldman, M.D., MPH, Sc.D.

Speaker

Grant or Contract
Grant or Contract

Pfizer Pharmaceuticals
BMS Foundation

Richard Furie, M.D.

Speaker

Professional Services
Professional Services
Professional Services
Professional Services
Professional Services
Professional Services

GlaxoSmithKline
Aurinia Pharmaceuticals
Genentech
AstraZeneca
Boehringer-Ingelheim
Kezar

Judith A. James, M.D., Ph.D.

Speaker

Grant or Contract
Grant or Contract
Grant or Contract

Novartis
GSK
Astra Zeneca

Kenneth Kalunian, M.D.

Speaker

None

N/A

David Karp, M.D., Ph.D.

Course Director, Moderator

Grant or Contract
Grant or Contract
Grant or Contract
Grant or Contract
Grant or Contract
Grant or Contract
Grant or Contract
Grant or Contract

Bristol-Myers Squibb
Celgene
Glaxo Smith-Kline
Genentech
Eli Lilly
Lupus Therapeutics
Biogen
PPD

Patti Katz, Ph.D.

Speaker

None

N/A

Alfred Kim, M.D., Ph.D.

Speaker

Grant or Contract
Grant or Contract
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor

GlaxoSmithKline
Foghorn Therapeutics
Alexion Pharmaceuticals
Aurinia Pharmaceuticals
Exagen Diagnostics
GlaxoSmithKline
Pfizer

Liz Lightstone, MBBS

Speaker

Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor

GSK
Biogen
Novartis
BMS
Alexion
Kezar
Astra Zeneca

Joan T. Merrill, M.D.

Speaker

Grant or Contract
Grant or Contract
Grant or Contract
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor

Astra Zeneca
Glaxo Smith Kline
Bristo Myers Squibb
Abbvie
Alexion
Amgen
Astra Zeneca
Aurinia
BMS
EMD Serono
Gilead
Glaxo Smith Kline
Lilly
Merck
Provention
Remegen
Sanofi
UCB
Zenas
Genentech

Chandra Mohan, M.D., Ph.D.

Speaker

Professional Services
Financial Support
Stock Options
Financial Support

Pharmacyclics/Abbvie
Equillium
Progentec
Hope Biosciences

Virginia Pascual, M.D.

Speaker

Grant or Contract
Grant or Contract
Patent
Professional Services
Professional Services

Sanofi
Astra Zeneca
Novartis
Sanofi
Astra Zeneca

Michelle Petri M.D., MPH

Speaker

Grant or Contract
Grant or Contract
Grant or Contract
Grant or Contract
Grant or Contract
Grant or Contract
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor
Independent Contractor

AstraZeneca
Eli Lilly
Exagen
GSK
Thermofisher
Janssen
Alexion
Amgen
AnaptysBio
AstraZeneca
Aurinia
Axdev
Emergent Biiosolutions
Gilead Biosciences
GSK
IQVIA
Janssen
Eli Lillly
Merck EMD Serono
Momenta Pharmaceuticals
Sanofi
UCB
Caribou Biosciences
Kira Pharmaceuticals
SinoMab Bioscience
Biogen
MedShr

Andres Quiceno, M.D.

Moderator

None

N/A

Lisa R. Sammaritano, M.D.

Speaker

None

N/A

Blair Solow, M.D.

Moderator

Grant or Contract

Pfizer

 

Educational Grants

The University of Texas Southwestern Medical Center gratefully acknowledges educational grants from the following companies in support of this CME activity: Aurinia Pharmaceuticals
 

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this internet enduring material activity for a maximum of 9.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit

  • 9.00 AMA
  • 9.00 Attendance
 
Status
Price
Title
$0.00Included
Please login or create an account to take this course.
$0.00Included
Please login or create an account to take this course.
$0.00Included
Please login or create an account to take this course.
$0.00Included
Please login or create an account to take this course.
$0.00Included
Please login or create an account to take this course.
$0.00Included
Please login or create an account to take this course.
$0.00Included
Please login or create an account to take this course.
$0.00Included
Please login or create an account to take this course.

Price

Cost:
$0.00
Please login or create an account to take this course.

Registration

To register:

  1. "Login" to your existing account or create an account in EthosCE, online learning management system, by selecting the "create an account" link.
  2. Return to this course page and select the "Enroll" button.
  3. Registration will be completed.
  4. You may select the link embedded in the session title from the listing under the "Register" tab to proceed to the activity.

Required Hardware/software

Activities will run on desktop or mobile device using the most recent version of common browsers, including Internet Explorer, Safari, Google Chrome or Mozilla Firefox.